Adam Brightman, | |
1740 Delong Road, Cornwall, VT 05753 | |
(802) 462-3755 | |
Not Available |
Full Name | Adam Brightman |
---|---|
Gender | Male |
Speciality | Social Worker - Clinical |
Location | 1740 Delong Road, Cornwall, Vermont |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1982735890 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
1041C0700X | Social Worker - Clinical | (Vermont) | Primary |
Mailing Address | Practice Location Address |
---|---|
Adam Brightman, 1740 Delong Road, Cornwall, VT 05753 Ph: () - | Adam Brightman, 1740 Delong Road, Cornwall, VT 05753 Ph: (802) 462-3755 |
News Archive
In a potentially huge change, Blue Cross and Blue Shield of Florida plans to enter the Medicaid program and compete in what likely will become a statewide managed-care system. Blue Cross, the state's largest health insurer, has stayed out of Medicaid in the past. But its new stance comes as Florida lawmakers seek to enroll almost all Medicaid beneficiaries in managed-care plans - and as last year's federal health law prepares to funnel more people into the system.
While many people are aware that drinking during pregnancy can lead to a range of Fetal Alcohol Spectrum Disorders (FASDs), including the serious Fetal Alcohol Syndrome (FAS), linkages between maternal-drinking measures and child outcomes have been inconsistent.
The Defense Advanced Research Projects Agency (DARPA), the research arm of the U.S. Department of Defense, has awarded Duke University $19.5 million for an effort led by the Duke Institute for Genome Sciences & Policy (IGSP) to design a portable, easy-to-use diagnostic device that can reveal who is infected with an upper respiratory virus before the first cough or sneeze.
Scientists in Taiwan have found that intravenous injections of stem cells derived from human exfoliated deciduous tooth pulp (SHED) have a protective effect against brain damage from heat stroke in mice. Their finding was safe and effective and so may be a candidate for successfully treating human patients by preventing the neurological damage caused by heat stroke.
BioMarin Pharmaceutical Inc. announced today that Genzyme notified the company that, in rare circumstances, it has detected foreign particles in some products filled at the Allston Landing facility. To ensure that patients are not exposed to foreign particles during product administration, Genzyme has issued a "Dear Doctor" letter to all physicians treating patients with enzyme replacement products that it markets, including Aldurazyme.
› Verified 1 days ago
David A Sandler, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 89 Ridge Rd, Cornwall, VT 05753 Phone: 802-462-3816 |